Targeting sequencing of PDA driver genes (19 genes, Table S1) identified mutations of Kras and Trp53 in tumour derived organoids (B6-Ks), thereby confirming that these two events are sufficient for the development of PDA in mice and are maintained in culture16. The gene discussed is TP53; the disease is Patent ductus arteriosus.